Side-by-side comparison of AI visibility scores, market position, and capabilities
HIPAA/FERPA-compliant school health EHR for K–12 nurse offices, serving 1M+ students across 2,000+ schools in 30 states; rebranded from CareDox; $91.9M raised.
SchoolCare (formerly CareDox) is a digital health technology company that partners with K–12 school nurse offices to provide HIPAA- and FERPA-compliant electronic health records, chronic disease management tools, and immunization compliance reporting. The company was founded under the CareDox name and rebranded to SchoolCare to better reflect its exclusive focus on the school health setting. SchoolCare's platform enables school nurses to document student health visits, manage chronic conditions (such as asthma, diabetes, and food allergies), track medication administration, and communicate securely with families — replacing paper-based systems that create compliance risks and administrative burden in school districts.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.